Geode Capital Management’s GlucoTrack GCTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.9K Sell
34,207
-12,794
-27% -$8.02K ﹤0.01% 4415
2026
Q1
$30.6K Buy
+47,001
New +$99.8K ﹤0.01% 4406
2025
Q1
Sell
-94
Closed -$42.1K 4490
2024
Q4
$42.1K Buy
94
+71
+309% +$90.2K ﹤0.01% 4270
2024
Q3
$65.5K Buy
+23
New +$55.9K ﹤0.01% 4205

Other funds holding GCTK

Geode Capital Management's GCTK Position: Q2 2026 in Review

Geode Capital Management reduced its GlucoTrack (GCTK) stake by 27% in Q2 2026, selling an estimated $8.02K and leaving 34,207 shares worth $10.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4415.

Geode Capital Management first reported a position in GCTK in Q3 2024 and has held it in 4 quarters since. The position peaked at $65.5K in Q3 2024. 18 funds tracked by Wall St. Rank hold GCTK as of Q2 2026.

  • Geode Capital Management held 34,207 shares of GlucoTrack worth $10.9K as of Q2 2026.
  • Geode Capital Management sold 12,794 GlucoTrack shares in Q2 2026, an estimated $8.02K.
  • GlucoTrack made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4415 holding.
  • Geode Capital Management first reported a position in GlucoTrack in Q3 2024 and has held it in 4 quarters since.
  • Geode Capital Management's GlucoTrack position peaked at $65.5K in Q3 2024.
  • 18 funds tracked by Wall St. Rank held GlucoTrack as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.